You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tucatinib

Showing 1 - 25 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in New York (Tucatinib)

Recruiting
  • Metastatic Breast Cancer
  • Tucatinib
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 26, 2023

Breast Cancer Trial (Tucatinib, Doxil)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 17, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

Metastatic Solid Tumor, Brain Metastases Trial in Houston (Trastuzumab emtansine, Tucatinib)

Not yet recruiting
  • Metastatic Solid Tumor
  • Brain Metastases
  • Trastuzumab emtansine
  • Tucatinib
  • Houston, Texas
    M D Anderson Cancer Center
Dec 30, 2022

HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)

Recruiting
  • HER2-positive Metastatic Breast Cancer
  • Aurora, Colorado
  • +2 more
Dec 29, 2022

Metastatic Breast Cancer, Advanced Breast Cancer, HER2-positive Breast Cancer Trial (Margetuximab, Tucatinib, Capecitabine)

Withdrawn
  • Metastatic Breast Cancer
  • +2 more
  • (no location specified)
Jul 6, 2022

Breast Cancer Trial (Tucatinib, Eribulin, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • Tucatinib
  • +2 more
  • (no location specified)
Jul 12, 2022

Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma Trial in United States (Trastuzumab,

Recruiting
  • Adenocarcinoma of the Rectum
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

Recruiting
  • Brain Metastases
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 8, 2022

Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Los Angeles (Tucatinib, Pembrolizumab, Trastuzumab)

Withdrawn
  • Breast Cancer
  • +3 more
  • Tucatinib
  • +2 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jun 28, 2022

Metastatic HER2+ Advanced Breast Cancer, Breast Tumors, Gastric or Gastroesophageal Junction Adenocarcinoma (GEC) Trial in

Recruiting
  • Metastatic HER2+ Advanced Breast Cancer
  • +3 more
  • Tucatinib
  • Harbin, Heilongjiang, China
  • +4 more
Nov 15, 2022

Breast Cancer Stage IV Trial in Clackamas, Newberg, Portland (Tucatinib)

Recruiting
  • Breast Cancer Stage IV
  • Tucatinib
  • Clackamas, Oregon
  • +3 more
Jan 12, 2022

Breast Cancer, HER2-positive Breast Cancer Trial in Australia (Tucatinib, Pembrolizumab, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Tucatinib
  • +3 more
  • Albury, New South Wales, Australia
  • +11 more
May 22, 2022

HER2-positive Metastatic Breast Cancer, Locally Advanced HER2 Positive Breast Carcinoma Trial in Spain (Tucatinib, Trastuzumab,

Not yet recruiting
  • HER2-positive Metastatic Breast Cancer
  • Locally Advanced HER2 Positive Breast Carcinoma
  • Tucatinib
  • +2 more
  • Cádiz, Andalucía, Spain
  • +17 more
Jan 16, 2023

Colorectal Tumors Trial in United States (tucatinib, trastuzumab, bevacizumab)

Recruiting
  • Colorectal Neoplasms
  • tucatinib
  • +7 more
  • Anaheim, California
  • +13 more
Aug 15, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

Metastatic Breast Cancer With a Isolated Brain Progression Trial in France (Tucatinib, Pertuzumab, Trastuzumab)

Recruiting
  • Metastatic Breast Cancer With a Isolated Brain Progression
  • Tucatinib
  • +4 more
  • Angers, France
  • +33 more
Aug 10, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Metastatic Breast Cancer, Leptomeningeal Disease Trial in United States (Tucatinib, Trastuzumab, Capecitabine)

Active, not recruiting
  • Metastatic Breast Cancer
  • Leptomeningeal Disease
  • Tucatinib
  • +2 more
  • Birmingham, Alabama
  • +8 more
Oct 12, 2021

HER2 Positive Breast Cancer Trial in United States (tucatinib, trastuzumab deruxtecan)

Recruiting
  • HER2 Positive Breast Cancer
  • tucatinib
  • trastuzumab deruxtecan
  • Birmingham, Alabama
  • +32 more
Oct 26, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Worldwide (tucatinib,

Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • tucatinib
  • +5 more
  • Birmingham, Alabama
  • +47 more
Oct 27, 2022

Breast Cancer Trial in Japan, Korea, Republic of, Taiwan (Tucatinib, Trastuzumab, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • Tucatinib
  • +2 more
  • Nagoya, Aichi, Japan
  • +27 more
Nov 30, 2022

Breast Cancer Trial (Tucatinib, Abemaciclib, Trastuzumab)

Withdrawn
  • Breast Cancer
  • Tucatinib
  • +3 more
  • (no location specified)
Oct 21, 2020

HER2-expressing Cancers Trial in Canada, Korea, Republic of, United States (ZW25 (Zanidatamab), Paclitaxel, Capecitabine)

Active, not recruiting
  • HER2-expressing Cancers
  • ZW25 (Zanidatamab)
  • +4 more
  • Birmingham, Alabama
  • +16 more
Feb 25, 2022

Uterine Tumors, Uterine Cervical Tumors, Biliary Tract Tumors Trial in Worldwide (tucatinib, trastuzumab, fulvestrant)

Recruiting
  • Uterine Neoplasms
  • +5 more
  • tucatinib
  • +2 more
  • Goodyear, Arizona
  • +63 more
Aug 15, 2022